Why I Think the Fertility Industry Needs Better Regulation

I never thought I’d be the type to casually analyze the pH of my cervical mucus over coffee, but here we are. The fertility industry has a knack for turning your most private moments into a string of clinical transactions, and I can’t decide which is worse—the emotional whiplash or the mountain of forms. Peel back the hopeful Instagram reveals and the waiting room magazines from 2012, and you’ll find a Wild West of medical practices that needs a sheriff, yesterday.

I’m Jenna Luisa Ferrer, and I write about the messy, often ridiculous collision of making life and navigating a system that sometimes feels like it was cobbled together by a committee of distracted toddlers. My own run through fertility treatments has been a cocktail of deep gratitude and low-simmering fury. I’ve squeezed my wife’s hand through failed IUIs, celebrated a positive beta that quickly dissolved into a chemical pregnancy, and sat through financial counseling sessions that made used-car salesmen look like saints. And through it all, one question kept gnawing at me: why is this industry held together with little more than hope and Scotch tape?

The Embryo Mix-Up That Haunts Me

Let’s start with the nightmare that keeps every IVF patient staring at the ceiling at 3 a.m. A few years back, a couple in California welcomed twins after a successful embryo transfer. The babies were gorgeous, healthy, and genetically unrelated to them. The clinic had accidentally implanted someone else’s embryos. The biological parents were eventually told, a custody fight erupted, and everyone’s life got blown apart. This isn’t a dystopian novel plot—it’s a real case that made headlines and then slipped quietly off the front page, leaving a trail of legal and emotional wreckage.

When I first stumbled across that story, I was in the thick of my own IVF cycle. I remember staring at the embryo photo the embryologist handed me—a grainy, black-and-white shot of a microscopic cell cluster—and thinking, “How do I know this one’s actually mine?” The honest answer is, I don’t. Clinics rely on manual labeling, double-checks by overworked staff, and the prayer that nobody sneezes near the petri dishes. There’s no federal rule requiring electronic witnessing systems, no universal barcoding, no independent body that audits these steps. It’s an honor system, and honor doesn’t mean much when you’re handling the raw ingredients of a human life.

Over in the UK, the Human Fertilisation and Embryology Authority (HFEA) mandates double-witnessing, traceability, and regular inspections. In the United States, the FDA treats donated eggs and sperm as “human tissue,” but embryos created for a couple’s own use fall into a regulatory void. The CDC collects success-rate data, but that’s just counting outcomes, not enforcing safety. The American Society for Reproductive Medicine (ASRM) publishes guidelines, but they’re optional. A clinic can shrug them off and keep its doors open. That’s not regulation—it’s a suggestion box with no lock.

The Financial Fog: Where Money Meets Desperation

If you’ve ever tried to price out an IVF cycle, you know it feels like trying to nail jelly to a wall. The base fee might be $12,000, but then come the add-ons: ICSI, assisted hatching, embryo glue, genetic testing, storage costs, meds that cost more than your rent. By the time you’re done, you’ve dropped $25,000 and you’re not entirely sure what half of those line items even do. Clinics bundle services in ways that make comparison shopping impossible, and they aren’t forced to reveal their live-birth rates per cycle in a simple, head-to-head format.

I once sat in a clinic’s financial office while a coordinator pitched me a “three-cycle package” with a money-back guarantee if I didn’t bring home a baby. It sounded like a used-car warranty. The fine print clarified that the guarantee only counted if I used my own eggs (I wasn’t), met narrow BMI criteria (I did, barely), and agreed to transfer every embryo they created, regardless of quality. It was a bet placed squarely on my desperation, and the house always wins. The lack of transparent pricing and honest outcome data means patients make life-altering money decisions based on glossy brochures and crossed fingers. That’s not informed consent—that’s a spin of the roulette wheel.

The Add-On Industrial Complex

Let’s talk about those add-ons. Embryo glue, for instance, is a substance that supposedly helps the embryo stick to the uterine wall. Sounds like magic, right? The evidence is flimsy. A Cochrane review found too little data to back its routine use, yet clinics push it for an extra $500 to $1,000. Endometrial scratching—intentionally roughing up the uterine lining to boost implantation—was trendy for years until a big randomized trial showed it didn’t work and might even do harm. Yet some clinics still offer it, because it’s a revenue stream and patients are ready to try anything.

I fell for the add-on trap myself. After two failed transfers, the doctor floated “assisted hatching,” where they punch a tiny hole in the embryo’s shell to help it hatch. I nodded, paid the fee, and later learned the ASRM considers it experimental for most patients. I wasn’t handed a consent form explaining the weak evidence; I was handed a price list. The fertility industry has perfected the art of selling hope in a syringe, and without regulation, no one stops them from peddling unproven treatments to people who are emotionally wrung out.

The Genetic Testing Wild West

Preimplantation genetic testing (PGT) is one of the most potent tools in modern fertility care—and one of the most misused. PGT-A screens embryos for chromosomal abnormalities, theoretically lifting the odds of a successful pregnancy and cutting miscarriage risk. But the marketing often gallops ahead of the science. Some clinics sell PGT-A as a way to “pick the healthiest embryo,” as if it can screen for everything from future cancer risk to eye color. It can’t. It’s a screening tool with limits, false positives, and the potential to discard embryos that might have self-corrected in the womb.

I’ve seen forums where women torment themselves over tossing “abnormal” embryos, only to later discover that the testing lab’s own data showed a meaningful chance of mosaicism—where an embryo has a mix of normal and abnormal cells—and that mosaic embryos can lead to healthy live births. But the counseling around PGT is often a quick chat. A nurse hands you a pamphlet, you tick a box, and suddenly you’re making decisions about which potential lives to keep based on a report you don’t fully grasp. There’s no standard for how clinics must present this info, no requirement for independent genetic counseling, and no real oversight of the labs running the tests. It’s a high-stakes guessing game dressed in lab-coat jargon.

The Emotional Toll of an Unregulated System

Beyond the clinical chaos and the money pit, there’s the emotional shrapnel that comes from moving through a system that treats you like a customer, not a patient. Fertility clinics are businesses, and they compete for your cash. That means polished websites, cherry-picked success stories, and a sales pitch that tends to glide past the real risks: ovarian hyperstimulation syndrome, multiples, ectopic pregnancies, and the psychological weight of repeated failure.

I’ve cried in more clinic bathrooms than I’d like to admit. After a failed transfer, I’d get a call from a nurse who sounded like she was reciting a script, followed by a billing statement that arrived before my period did. There was no mental health screening, no mandatory counseling, no support group referral unless I clawed one out myself. The industry profits from our hope, but it mostly leaves us to sweep up the emotional mess alone. Regulation could require psychological support, force clinics to provide realistic outcome data tailored to individual profiles, and enforce ethical marketing. Instead, we’re left Googling “IVF failure depression” at 2 a.m.

The Donor Conception Black Box

If you think IVF regulation is loose, the donor gamete world is the Wild West’s rowdier cousin. Sperm banks and egg donor agencies operate with barely a whisper of federal oversight. Donors can give at multiple banks, leading to dozens of genetic half-siblings. There’s no mandatory cap on offspring per donor, no central registry, and no requirement for long-term medical follow-up. The FDA demands infectious disease screening, but genetic carrier screening is patchy, and psychological evaluation of donors often feels like a quick formality.

I’ve read accounts of donor-conceived adults who found out they have 50-plus half-siblings, all from the same donor, all living in the same region. The potential for accidental incest is real and deeply unsettling. Some countries, like the UK and Sweden, have donor registries and limits on family size. The US has nothing. Parents using donors often get a childhood photo and a short profile, and are told to trust the bank did its homework. But homework without regulation is just a promise, and promises don’t hold up in court when your kid wants to know their genetic roots.

What Better Regulation Could Look Like

I’m not anti-industry. I’m pro-patient. The fertility industry gave me my daughter, and I’ll be grateful for that forever. But gratitude shouldn’t silence criticism. We can push for better without biting the hand that helped us. So what would meaningful regulation actually look like? First, a federal oversight body modeled on the UK’s HFEA, with teeth to license clinics, inspect labs, and enforce standards. Second, mandatory reporting of every embryo mix-up, error, and adverse event, with public disclosure. Third, standardized pricing and outcome reporting so patients can compare apples to apples. Fourth, limits on donor offspring and a national donor registry. Fifth, required informed consent that includes evidence-based counseling on add-ons and genetic testing.

Some will argue that regulation chokes innovation and jacks up costs. But the current system already chokes trust and jacks up emotional costs. When a clinic loses an embryo, the cost isn’t just measured in dollars; it’s generational. We regulate airlines, pharmaceuticals, and even pet food more tightly than we regulate the creation of human life. That’s not a quirky fact; it’s embarrassing.

The Power of Patient Stories

Change often starts with stories. The #MeToo movement, the fight for marriage equality, the push for mental health awareness—all gathered force because people were brave enough to say, “This happened to me, and it’s not okay.” The fertility industry needs its own chorus. I’m adding my voice, with all its dark humor and lingering resentment, because silence costs too much. If you’ve stumbled through this maze, you know the secrets it keeps. Share them. Write about the hidden fees, the misleading stats, the moment you realized you were just a number on a spreadsheet. The more we talk, the harder it is for the industry to hide behind its highlight reels.

I’m not naive. Regulation won’t fix everything. It won’t make IVF painless or guarantee a baby. But it could make the process safer, fairer, and less predatory. It could mean fewer mix-ups, fewer financial traps, and fewer nights wondering if you made a terrible mistake with your embryos. For an industry built on creating families, that feels like the bare minimum.

So here I am, a mother made through science and stubbornness, asking for a system that honors the weight of what it does. The fertility industry gave me my family, but it also gave me a front-row seat to its cracks. I’m not just a grateful customer; I’m a witness. And I think it’s time we all started testifying.